US · Healthcare

Cell Source Inc (CLCS)

Biotechnology

Cell Source Inc (CLCS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CLCS

P/E ratio

18.00

Cell Source Inc (CLCS) — FAQ

What is CLCS's P/E ratio?

The price-to-earnings (P/E) ratio for Cell Source Inc (CLCS) is 18.00 (data as of 2026-03-23).

Does Cell Source Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cell Source Inc (CLCS). Check the MyAverix Finance app for the latest dividend data.

What sector is Cell Source Inc in?

Cell Source Inc (CLCS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CLCS listed on?

CLCS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)